Skip to main content

Anika Therapeutics, Inc 10-Q for FY2024 Q3

Anika Therapeutics, Inc. (ANIK)

10-Q 2024-11-04 For: 2024-09-30
View Original
Added on April 06, 2026

About this 10-Q

Anika Therapeutics, Inc filed this 10-Q on November 4, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$38.75M
down 6.5% from $41.47M a year earlier
Net loss
$29.92M
compared with a net loss of $6.58M a year earlier
Diluted EPS
-$2.03
compared with -$0.45 a year earlier